Biocon informs about press release

28 Jan 2026 Evaluate
Biocon has informed that it enclosed the press release titled ‘S&P Global Upgrades Biocon Biologics Credit Rating To ‘BB+’ Revises Outlook to ‘Stable’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

364.00 -6.15 (-1.66%)
29-Jan-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1199.20
Cipla 1311.90
Zydus Lifesciences 884.65
Lupin 2104.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×